tradingkey.logo
tradingkey.logo
Search

Akebia Therapeutics Inc

AKBA
Add to Watchlist
1.220USD
0.0000.00%
Close 07-24 16:00ETQuotes delayed by 15 min
326.84MMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-24
Previous score
3.00
Change
0
The current institutional shareholding score of Akebia Therapeutics Inc is 3.00, ranking 92 out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 46.96%, representing a quarter-over-quarter increase of 1.21%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.68% of shares outstanding, with 0.48% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
17.42M
+4.13%
State Street Investment Management (US)
13.69M
+15.56%
Geode Capital Management, L.L.C.
6.28M
+1.49%
Alerce Investment Management, L.P.
5.75M
--
Satter Muneer A
5.75M
--
Citadel Advisors LLC
4.67M
+46.45%
Goldman Sachs & Company, Inc.
4.19M
+230.63%
Renaissance Technologies LLC
Star Investors
3.59M
-9.10%
Qube Research & Technologies Ltd
2.99M
-6.72%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.